Hutter Family Professor of Medicine, Harvard Medical School and Roman DeSanctis Endowed Clinical Scholar in Medicine Massachusetts General Hospital.
Cardiology
James Januzzi is an expert in the field of Cardiology. He graduated from New York Medical College. He has 28 awards "Simon Dack Award", "Elite Reviewer", "Brian A. McGovern Memorial Award for Excellence in Clinical Teaching", "Sheila and John Balson Cardiac Scholar Award", "Nathaniel Bowditch Award", "Best of Boston, Cardiology", "Whos Who in Medicine", "Whos Who in Science and Research", "Americas Top Cardiologists", "Visiting Professor, Alpha Omega Alpha", "Outstanding Speaker Award", "Best Doctors", "Hospital Award for Excellence: the PRIDE Study, Clinical Research Day", "Fellow of the American College of Cardiology", "Partners in Excellence Award", "Bristol Myers Squibb Cardiology Fellows Forum Scholarship", "Roman W. DeSanctis, M.D., Clinical Scholar Award", "Dr. and Mrs. David Harrison Scholarship Award", "Irving Innerfield, M.D., Memorial Award in Internal Medicine", "Stephen P. Jewett, M.D., Memorial Award in Psychiatry", "Eileen H. Pike, M.D., Ph.D., Memorial Award in Microbiology", "David Spiro, M.D., Ph.D., Memorial Award in Pathology", "Citation for Service, Cor et Manus", "President, Iota Chapter, Alpha Omega Alpha Medical Honor Society", "First Prize, New York Medical College Research Forum", "New York Medical College Trustee's Scholarship", "Top MD" and "Fellow (FACC)". James Januzzi is a published MD. He published 97 publications, including: 'Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.'
Publications
- Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study.
- Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.
- Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.
- Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department.
- hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT I...
- The Biology of ST2: The International ST2 Consensus Panel.
- ST2 in Pulmonary Disease.
- The International ST2 Consensus Panel: Introduction.
- Sensitive troponin assays in patients with suspected acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomog...
- ST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus Panel.
- Concentrations of Highly Sensitive Cardiac Troponin-I Predict Poor Cardiovascular Outcomes and Adverse Remodeling in Chronic Heart Failure.
- Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction.
- The Potential Role of Natriuretic Peptide-Guided Management for Patients Hospitalized for Heart Failure.
- Outcomes of patients with acute decompensated heart failure managed by cardiologists versus noncardiologists.
- Cystatin C-based CKD-EPI Equations and N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Outcomes in Acutely Decompensated Heart Failure.
- Characterization and Prediction of Adverse Events From Intensive Chronic Heart Failure Management and Effect on Quality of Life: Results From the Pro-B-Type Natriureti...
- Effects of Left Ventricular Assist Device Support on Biomarkers of Cardiovascular Stress, Fibrosis, Fluid Homeostasis, Inflammation, and Renal Injury.
- Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction.
- Validation of the Barcelona Bio-Heart Failure Risk Calculator in a cohort from Boston.
- Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the framingham offspring study.
- Rationale and Design of the GUIDE-IT Study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.
- Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function?
- Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers.
- Coronary Sinus Biomarker Sampling Compared to Peripheral Venous Blood for Predicting Outcomes In Patients with Severe Heart Failure Undergoing Cardiac Resynchronizatio...
- Acute Coronary Syndrome Antiplatelet Alternatives in Clopidogrel Allergy.
- Impact of Statin Use on Exercise-Induced Cardiac Troponin Elevations.
- Charting a Roadmap for Heart Failure Biomarker Studies.
- Can copeptin emerge from the growing shadow of the troponins?
- Different vascular responses within the same stent detected by optical coherence tomography.
- Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.
- Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients: correlation to mortality and length of stay.
- Collaborative Care for Depression and Anxiety Disorders in Patients With Recent Cardiac Events: The Management of Sadness and Anxiety in Cardiology (MOSAIC) Randomized...
- Soluble ST2 and Galectin-3 in Heart Failure.
- Natriuretic Peptides in Heart Failure and Acute Coronary Syndrome.
- Galectin-3 expression in cardiac remodeling after myocardial infarction.
- Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.
- Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure.
- Reference Interval Evaluation of High Sensitivity Troponin T and N-Terminal B-Type Natriuretic Peptide in Vietnam and the US: The North South East West Trial.
- Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.
- Soluble Concentrations of the Interleukin Receptor Family Member ST2 and β-Blocker Therapy in Chronic Heart Failure.
- Body mass index and mortality in acutely decompensated heart failure across the world: A global obesity paradox.
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
- Patient Health Questionnaire-9 score and adverse cardiac outcomes in patients hospitalized for acute cardiac disease.
- Biomarkers in ACS and Heart Failure: Should Men and Women Be Interpreted Differently?
- The Importance of Rigorous Evaluation in Comparative Biomarker Studies.
- Design and baseline data from the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized controlled trial.
- The IRAD Classification System for Characterizing Survival after Aortic Dissection.
- Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress Syndrome.
- The Role of B-Type Natriuretic Peptide Testing in Guiding Outpatient Heart Failure Treatment.
- Natriuretic Peptides as Biomarkers in Heart Failure.
- Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
- Interleukin receptor family member ST2 concentrations in patients following heart transplantation.
- ST2 as a Cardiovascular Risk Biomarker: From the Bench to the Bedside.
- Natriuretic peptides, ejection fraction, and prognosis: Parsing the phenotypes of heart failure.
- QTc prolongation, torsades de pointes, and psychotropic medications.
- Single Resting hsTnT Level Predicts Abnormal Myocardial Stress Test in Acute Chest Pain Patients With Normal Initial Standard Troponin.
- Association Between Elevated Blood Glucose and Outcome in Acute Heart Failure: Results From an International Observational Cohort.
- Biomarkers and diagnostics in heart failure.
- High-sensitivity troponin T and C-reactive protein to identify patients without cardiac structural and functional abnormalities as assessed by cardiac CT and SPECT ima...
- Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
- Are Serial BNP Measurements Useful in Heart Failure Management?: Serial Natriuretic Peptide Measurements Are Useful in Heart Failure Management.
- Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure.
- ?-Trace Protein: From GFR Marker to Cardiovascular Risk Predictor.
- Characterization and Prediction of Natriuretic Peptide "Nonresponse" During Heart Failure Management: Results From the ProBNP Outpatient Tailored Chronic Heart Failure...
- Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study.
- The Role of Natriuretic Peptides as Biomarkers for Guiding the Management of Chronic Heart Failure.
- Highly sensitive troponin T in patients with acute ischemic stroke.
- Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from th...
- Use of biomarkers to guide outpatient therapy of heart failure.
- Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) s...
- Third universal definition of myocardial infarction.
- Usefulness of beta-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
- Using Biomarkers to "Guide" Heart Failure Management: Current Perspectives and Future Directions.
- Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.
- Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy.
- Acute aortic intramural hematoma: an analysis from the International Registry of Acute Aortic Dissection.
- Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure.
- Natriuretic peptide testing for predicting adverse events following heart failure hospitalization.
- Heart Failure Outcomes and Benefits of NT-proBNP-Guided Management in the Elderly: Results From the Prospective, Randomized ProBNP Outpatient Tailored Chronic Heart Fa...
- Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patients.
- What is the role of serial high-sensitivity troponin measurements in chronic heart failure?
- Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section.
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients treated with Anthracyclines, Taxanes and Trastuzumab.
- Multi-marker strategy of natriuretic peptide with either conventional or high-sensitivity troponin-T for acute coronary syndrome diagnosis in emergency department pati...
- Risk factors for positive depression screens in hospitalized cardiac patients.
- Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness.
- Emerging Biomarkers in Heart Failure.
- Soluble ST2 Is a Marker for Acute Cardiac Allograft Rejection.
- Use of amino-terminal pro-B-type natriuretic Peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.
- Type-Selective Benefits of Medications in Treatment of Acute Aortic Dissection (from the International Registry of Acute Aortic Dissection [IRAD]).
- Safety of Antipsychotics in the Setting of QTc Prolongation: The Utility of the JT Index.
- Short-term variability of heart rate turbulence in chronic heart failure.
- A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department.
- Use of biomarkers to "guide" care in chronic heart failure: what have we learned (so far)?
- Activated Leukocyte Cell Adhesion Molecule and Prognosis in Acute Ischemic Stroke.
- Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.
Schools
New York Medical College
Saint Vincent39s Hospital
Doctors Specialties
- Gastroenterology
- Cardiology
Accepted Insurances
Awards
- Simon Dack Award
- Elite Reviewer
- Brian A. McGovern Memorial Award for Excellence in Clinical Teaching
- Sheila and John Balson Cardiac Scholar Award
- Nathaniel Bowditch Award
- Best of Boston, Cardiology
- Who’s Who in Medicine
- Who’s Who in Science and Research
- America’s Top Cardiologists
- Visiting Professor, Alpha Omega Alpha
- Outstanding Speaker Award
- Best Doctors
- Hospital Award for Excellence: the PRIDE Study, Clinical Research Day
- Fellow of the American College of Cardiology
- Partners in Excellence Award
- Bristol Myers Squibb Cardiology Fellows Forum Scholarship
- Roman W. DeSanctis, M.D., Clinical Scholar Award
- Dr. and Mrs. David Harrison Scholarship Award
- Irving Innerfield, M.D., Memorial Award in Internal Medicine
- Stephen P. Jewett, M.D., Memorial Award in Psychiatry
- Eileen H. Pike, M.D., Ph.D., Memorial Award in Microbiology
- David Spiro, M.D., Ph.D., Memorial Award in Pathology
- Citation for Service, Cor et Manus
- President, Iota Chapter, Alpha Omega Alpha Medical Honor Society
- First Prize, New York Medical College Research Forum
- New York Medical College Trustee's Scholarship
- Top MD
- Fellow (FACC)
Education
-
Massachusetts General Hospital
-
Brigham and Women's Hospital
-
New York Medical College
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER |
|
1699757062 |
| NPPES Provider LastName |
|
JANUZZI |
| NPPES Provider FirstName |
|
JAMES |
| NPPES Provider ZIPCode |
|
021142696 |
| NPPES Provider State |
|
MA |
| Specialty Description |
|
Cardiology |
| Total Claim Count |
|
2004.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1699757062 |
| Last Name Of The Provider |
JANUZZI |
| First Name Of The Provider |
JAMES |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.